Previous Article | Next Article ![]()
Infection and Immunity, April 1999, p. 1633-1639, Vol. 67, No. 4
Department of Operative Dentistry and
Endodontology,
Received 8 September 1998/Returned for modification 2 November
1998/Accepted 19 January 1999
We investigated whether vascular endothelial growth factor (VEGF)
production by human pulp cells (HPC) is regulated by lipopolysaccharide (LPS) in relation to the pathogenesis of pulpitis. Although HPC incubated with medium alone only marginally expressed VEGF mRNA and
produced a low level of VEGF as detected by enzyme-linked immunosorbent
assay, the VEGF mRNA expression and VEGF production were markedly
enhanced upon stimulation with LPS from Escherichia coli.
Prevotella intermedia LPS, phorbol 12-myristate 13-acetate, and
interleukin-6 also induced VEGF mRNA expression in HPC. A simian virus
40-infected HPC line also exhibited increased VEGF mRNA expression in
response to E. coli LPS, but lung and skin fibroblasts did
not. Fetal bovine serum (FBS) increased the sensitivity of HPC to LPS
in a dose-dependent manner. HPC did not express membrane CD14 on their
surfaces. However, the anti-CD14 monoclonal antibody MY4 inhibited VEGF
induction upon stimulation with LPS in HPC cultures in the presence of
10% FBS but not in the absence of FBS. LPS augmented the VEGF
production in HPC cultures in the presence of recombinant human soluble
CD14 (sCD14). To clarify the mechanisms of VEGF induction by LPS, we
examined the possible activation of the transcription factor AP-1 in
HPC stimulated with LPS, by a gel mobility shift assay. AP-1 activation
in HPC was clearly observed, whereas that in skin fibroblasts was not. The AP-1 inhibitor curcumin strongly inhibited LPS-induced VEGF production in HPC cultures. In addition, a protein synthesis inhibitor, cycloheximide, inhibited VEGF mRNA accumulation in response to LPS.
These results suggest that the enhanced production of VEGF in HPC
induced by LPS takes place via an sCD14-dependent pathway which
requires new protein synthesis and is mediated in part through AP-1 activation.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lipopolysaccharide Enhances the Production of
Vascular Endothelial Growth Factor by Human Pulp Cells in
Culture
*
Corresponding author. Mailing address: Department of
Operative Dentistry and Endodontology, Kagoshima University Dental
School, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan. Phone and fax: 81-99-275-6190. E-mail:
toriim{at}dentb.hal.kagoshima-u.ac.jp.
Infection and Immunity, April 1999, p. 1633-1639, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»